Manufacturing and Production

Showing 15 posts of 5869 posts found.

Sale of Organon facility in Oss may avert closure

February 15, 2011 Manufacturing and Production Merck & Co, Netherlands, Oss

The fate of an Organon manufacturing and R&D facility in the Netherlands, currently under threat of closure by parent company …

R&D productivity worse than previously reported

February 15, 2011 Manufacturing and Production, Research and Development, Sales and Marketing BIO, BMT, FDA, R&D

A new analysis of pharma’s R&D pipelines suggests the overall success rate for drugs moving from clinical trials to FDA …
Biberach

Pharmaceutical manufacturing news in brief

February 15, 2011 Manufacturing and Production Boehringer Ingelheim, DSM Biologics, Elan, Novasep

Irish drugmaker Elan has forged an alliance with Boehringer Ingelheim to develop and manufacture antibody-based therapeutics. Under the terms of …
Blog footer

Digital Pharma: This is how pharma is using digital

February 10, 2011 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Android, Digital Pharma blog, Facebook, Twitter, disease awareness campaigns, ipad, iphone, social media

Pharma’s use of digital tools, from mobile apps to online campaigns to social media channels, is increasing all the time …

Genzyme to divest pharma intermediates business

February 8, 2011 Manufacturing and Production Cerezyme, Corden Pharma Switzerland, Corden Pharma group, Genzyme, International Chemical Investors Group, Sekisui Chemical Co, imiglucerase

Genzyme has agreed to sell off its pharmaceutical intermediates business to International Chemical Investors Group, a holding company which has …

Pharmaceutical facility news in brief

February 8, 2011 Manufacturing and Production Baxter International, Famar, Lannett, Qatar Pharma, Sanofi-Aventis, Takeda Pharmaceutical Co

A round-up of news involving manufacturing facilities includes updates from Takeda, Famar/Sanofi, Qatar Pharma, Lannett and Baxter. Takeda Pharmaceutical Co …

Stabilitech appoints new commercial director

February 8, 2011 Manufacturing and Production Donna Hackett, Stabilitch, appointment, manufacturing and production

Donna Hackett joins stabilisation company Stabilitch as commercial director. She has 20 years pharma experience, most recently at pre-clinical, clinical …

Teva plant in Israel cited by FDA, expands in Americas

February 8, 2011 Manufacturing and Production Corporacion Infarmasa, FDA, Peru, Teva, Teva Pharmaceutical, generics, generics manufacturing, manufacturing compliance

A manufacturing facility in Jerusalem operated by Teva Pharmaceutical failed to pass muster in an FDA inspection, prompting a warning …

Avecia Biotech sold to Nitto Denko

February 8, 2011 Manufacturing and Production Avecia, Avecia Biologics, Avecia Biotechnology, Nitto Denko

Avecia Biotechnology, which focuses mainly on the development and manufacturing of oligonuceotide medicines, has been acquired by Japanese firm Nitto …

Five capabilities of centered leadership

February 3, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Caroline Webb, Joanna Barsh, Josephine Mogelof, McKinsey & Company, leadership

The business environment has become more demanding: the global financial crisis and subsequent economic downturn have ratcheted up the pressure …

FDA process validation guidelines emphasise risk management

February 1, 2011 Manufacturing and Production FDA, ICH, process validation

The FDA has published the final version of its Guideline on Process Validation, more than two years after the first …

Oxford BioMedica buys decommissioned facility

February 1, 2011 Manufacturing and Production Oxford BioMedica, RecipharmCobra Biologics, manufacturing

Gene therapy specialist Oxford BioMedica has said it plans to acquire a £1.9 million ($3.1m) manufacturing facility from contract manufacturer …

Mitsubishi Tanabe recalls two million injectables

January 28, 2011 Manufacturing and Production Mitsubishi, injectables, recall

Mitsubishi Tanabe Corp has said it will recall two million of its injectable medicines made at a facility in Ashikaga, …

David Jukes promoted to president of Univar Europe

January 25, 2011 Manufacturing and Production David Jukes, John van Osch, manufacturing and production, univar

Chemical distributor Univar has promoted David Jukes to president of its European operations. He replaces John van Osch who is …

Genzyme plans new Belgium facility

January 25, 2011 Manufacturing and Production Belgium, Genzyme, Lumizyme, Myozyme, Pompe disease, Sanofi-Aventis, alglucosidase alfa

US rare disease drug specialist Genzyme, the subject of a hostile takeover offer from France’s Sanofi-Aventis, says that it will …
The Gateway to Local Adoption Series

Latest content